Successful treatment of oral potentially malignant lesions with ruxolitinib in STAT3 gain-of-function disease

被引：3
|
作者：
Mulvihill, Ciara [1 ]
Fitzgerald, Kirsten [2 ,3 ]
O'Regan, Esther [1 ]
Healy, Claire M. [1 ]
Leahy, Timothy Ronan [4 ,5 ]
机构：
[1] Trinity Coll Dublin, Dublin Dent Univ Hosp, Dept Oral & Maxillofacial Surg, Oral Med & Oral Pathol, Dublin, Ireland
[2] Childrens Hlth Ireland Crumlin, Dept Paediat Dent, Dublin, Ireland
[3] Dublin Dent Univ Hosp, Dublin, Ireland
[4] Childrens Hlth Ireland Crumlin, Dept Paediat Immunol & Infect Dis, Dublin, Ireland
[5] Univ Dublin, Trinity Coll, Sch Med, Dept Paediat, Dublin, Ireland
来源：
ORAL ONCOLOGY | 2022年 / 132卷
关键词：
MUTATIONS;
D O I：
10.1016/j.oraloncology.2022.106015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 22 条
  • [1] Ruxolitinib treatment ameliorates clinical, immunologic, and transcriptomic aberrations in patients with STAT3 gain-of-function disease
    Catak, Feyza Bayram
    Catak, Mehmet Cihangir
    Babayeva, Royala
    Toubia, John
    Warnock, Nicholas I.
    Celmeli, Fatih
    Hafizoglu, Demet
    Yakici, Nalan
    Kayaoglu, Basak
    Surucu, Naz
    Gungoren, Ezgi Yalcin
    Can, Salim
    Altunbas, Melek Yorgun
    Karakus, Ibrahim Serhat
    Kiykim, Ayca
    Orhan, Fazil
    Eltan, Sevgi Bilgic
    Karakoc-Aydiner, Elif
    Ozen, Ahmet
    Erman, Baran
    Gursel, Mayda
    Kok, Chung Hoow
    Ciidr, Gokhan
    Baris, Safa
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (03) : 784 - 791
  • [2] Early-onset, fatal interstitial lung disease in STAT3 gain-of-function patients
    Gothe, Florian
    Gehrig, Jonathan
    Rapp, Christina K.
    Knoflach, Katrin
    Reu-Hofer, Simone
    Langer, Florian
    Schramm, Dirk
    Ley-Zaporozhan, Julia
    Ehl, Stephan
    Schwerk, Nicolaus
    Faletti, Laura
    Griese, Matthias
    PEDIATRIC PULMONOLOGY, 2021, 56 (12) : 3934 - 3941
  • [3] A patient-based murine model recapitulates human STAT3 gain-of-function syndrome
    Meesilpavikkai, Kornvalee
    Zhou, Zijun
    Kaikaew, Kasiphak
    Phakham, Suphattra
    van der Spek, Peter J.
    Swagemakers, Sigrid
    Venter, Deon J.
    de Bie, Maaike
    Schrijver, Benjamin
    Schliehe, Christopher
    Kaiser, Fabian
    Dalm, Virgil A. S. H.
    van Hagen, P. Martin
    Hirankarn, Nattiya
    Ijspeert, Hanna
    Dik, Willem A.
    CLINICAL IMMUNOLOGY, 2024, 266
  • [4] Phenotypes of STAT3 gain-of-function variant related to disruptive regulation of CXCL8/STAT3, KIT/STAT3, and IL-2/CD25/Treg axes
    Marega, Lia Furlaneto
    Sabino, Janine Schincariol
    Pedroni, Marcus Vinicius
    Teocchi, Marcelo
    Lanaro, Carolina
    de Albuquerque, Dulcineia Martins
    dos Santos, Irene Pereira
    Costa, Fernando Ferreira
    dos Santos Vilela, Maria Marluce
    IMMUNOLOGIC RESEARCH, 2021, 69 (05) : 445 - 456
  • [5] STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria
    Sauer, Merle
    Scheffel, Joerg
    Frischbutter, Stefan
    Mahnke, Niklas
    Maurer, Marcus
    Burmeister, Thomas
    Krause, Karoline
    Metz, Martin
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] Successful Rezafungin Treatment of an Azole-Resistant Chronic Mucocutaneous Candidiasis in a STAT-1 Gain-of-Function Patient
    Melenotte, Clea
    Ratiney, Robert
    Hermine, Olivier
    Bougnoux, Marie-Elisabeth
    Lanternier, Fanny
    JOURNAL OF CLINICAL IMMUNOLOGY, 2023, 43 (06) : 1182 - 1184
  • [7] A human STAT3 gain-of-function variant confers T cell dysregulation without predominant Treg dysfunction in mice
    Schmitt, Erica G.
    Toth, Kelsey A.
    Risma, Samuel I.
    Kolicheski, Ana
    Saucier, Nermina
    Berrios, Rafael J. Feliciano
    Greenberg, Zev J.
    Leiding, Jennifer W.
    Bleesing, Jack J.
    Thatayatikom, Akaluck
    Schuettpelz, Laura G.
    Edwards, John R.
    Vogel, Tiphanie P.
    Cooper, Megan A.
    JCI INSIGHT, 2022, 7 (21)
  • [8] STAT1 and STAT3 gain of function: clinically heterogenous immune regulatory disorders
    Olbrich, Peter
    Freeman, Alexandra F.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 24 (06) : 440 - 447
  • [9] Novel STAT-3 gain-of-function variant with hypogammaglobulinemia and recurrent infection phenotype
    Erdos, Melinda
    Tsumura, Miyuki
    Kallai, Judit
    Lanyi, Arpad
    Nyul, Zoltan
    Balazs, Gyorgy
    Okada, Satoshi
    Marodi, Laszlo
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2021, 205 (03): : 354 - 362
  • [10] Tocilizumab Promotes Regulatory T-cell Alleviation in STAT3 Gain-of-function associated Multi-organ Autoimmune Syndrome
    Khoury, Tawfik
    Molho-Pessach, Vered
    Ramot, Yuval
    Ayman, Abu Rmeileh
    Elpeleg, Orly
    Berkman, Neville
    Zlotogorski, Abraham
    Ilan, Yaron
    CLINICAL THERAPEUTICS, 2017, 39 (02) : 444 - 449
123